Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Swiss Roche posts USD10.6b profit in 2012  Join our daily free Newsletter

MENAFN - 30/01/2013

No. of Ratings : 0
Add to Mixx!


 


(MENAFN) Swiss Roche Holding's AG CEO, Severin Schwan, announced that the company's net profit for 2012 rose by 2.4 percent to USD10.6 billion, up from USD10.31 billion in 2011, reported AP.

Schwan said that total sales grew 4 percent, reaching USD49.2 billion in the year.

The CEO attributed the growth partially to the introduction of Perjeta, the breast cancer drug that helps women with HER2-positive breast cancer live longer, in the US and Europe.

Furthermore, there was strong demand for the Basel-based firm's clinical laboratory products in the year, with the diagnostics division, which introduced a number of new instruments and devices, posting a gain of 4 percent in sales to USD11.13 billion.

It is worth noting that Roche's top-selling products MabThera/Rituxan, Herceptin and Avastin all performed well in 2012, due to high demand in all regions.

 






  MENA News Headlines


 






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help